30.12
+4.58%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Kestra Medical Technologies
From its filings with the US Securities and Exchange Commission
Kestra Medical Technologies is based in Kirkland, Washington and is incorporated in Bermuda. Its shares trade on Nasdaq under the ticker KMTS. The SEC classifies its business as surgical & medical instruments & apparatus. In the fiscal year to 30 April 2026, it reported revenue of $95.1m and a net loss of $131.6m. At that date it held total assets of $358.5m and shareholders' equity of $259.7m.
Our Cardiac Recovery System platform is anchored by the ASSURE® Wearable Cardioverter Defibrillator (“WCD”), which continuously monitors patient heart rhythms and automatically delivers defibrillation therapy when life-threatening ventricular arrhythmias are detected. The platform also includes digital patient engagement and clinical workflow solutions designed to improve patient adherence, support care coordination, and provide actionable clinical insights throughout the recovery process.
We believe the ASSURE WCD is differentiated by its patient-centered design, including comfort, wearability, and low false alarm rates, which are intended to improve patient compliance during extended wear periods. In addition, our integrated platform generates continuous cardiac rhythm data and clinically actionable insights that may assist healthcare providers in managing patients during vulnerable recovery periods. We believe these capabilities position Kestra to participate in the growing cardiac recovery market and support future platform expansion opportunities. As of April 30, 2026, our ASSURE WCD has protected nearly 40,000 patients since commercial launch.
Quoted from its 10-K, filed 14 Jul 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 6 Mar 2025
- Employees
- 443
- Website
- kestramedical.com ↗
- Head office
- 3933 LAKE WASHINGTON BLVD NE, KIRKLAND, WA, 98033
- Incorporated in
- D0
- Classification
- Surgical & Medical Instruments & Apparatus
- Filer status
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Leadership
Pay as last reported
- Mr. Brian WebsterPresident, Chief Executive Officer, Director
- Mr. Vaseem MahboobChief Financial Officer
- Ms. Debra SchotzSenior Vice President - Marketing
- Mr. Michael GillSenior Vice President - Commercial Operations
- Ms. Traci UmbergerChief Administrative Officer, General Counsel, Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- The Cardiac Recovery System platform integrates monitoring and therapeutic treatment technologies.
- The ASSURE WCD protects patients at elevated risk of sudden cardiac arrest.
- The company operates as a commercial-stage wearable medical device provider.
Weaknesses
- The firm has only 443 employees in the Health Care sector.
- The company went public on 6 March 2025 with limited history.
- The headquarters is located in Kirkland, Washington, limiting local market reach.
Opportunities
- The digital health solutions support comprehensive patient care for cardiovascular disease.
- The therapeutic intervention technologies aim to transform patient outcomes significantly.
- The unified solution combines digital health with patient support services effectively.
Threats
- The market for wearable cardioverter defibrillators faces intense competitive pressure.
- Regulatory changes in the Health Care sector may impact operations.
- Technological obsolescence could reduce the effectiveness of the ASSURE WCD.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.